4.7 Review

Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 128, 期 -, 页码 29-53

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2018.04.001

关键词

Microfluidics; Drug delivery; Nanotechnology; Nanomedicine; Organ-on-a-chip; 3D culture

资金

  1. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2015R1A2A1A09005662, 2016R1A4A1010796]
  2. American Heart Association National Scientist Development Grant [15SDG25080314]
  3. National Science Foundation CAREER award [CMMI 1653006]

向作者/读者索取更多资源

Microfluidic technologies employ nano and microscale fabrication techniques to develop highly controllable and reproducible fluidic microenvironments. Utilizing microfluidics, lead compounds can be produced with the controlled physicochemical properties, characterized in a high-throughput fashion, and evaluated in in vitro biomimetic models of human organs; organ-on-a-chip. As a step forward from conventional in vitro culture methods, microfluidics shows promise in effective preclinical testing of nanoparticle-based drug delivery. This review presents a curated selection of state-of-the-art microfluidic platforms focusing on the fabrication, characterization, and assessment of nanoparticles for drug delivery applications. We also discuss the current challenges and future prospects of nanoparticle drug delivery development using microfluidics. (C) 2018 Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据